Titan Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Titan Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 207% to $184,000. The net income raised on -$5,569,000 and profit margin reached -3027%. Total operating expenses were $7,461,000.
Profit Margin
| 2014 | 3.64M | -2.40M | -65.91% |
|---|---|---|---|
| 2015 | 1.67M | -11.27M | -674.99% |
| 2016 | 15.06M | 5.13M | 34.09% |
| 2017 | 215K | -14.30M | -6654.42% |
| 2018 | 5.91M | -9.02M | -152.65% |
| 2019 | 3.61M | -16.08M | -445.56% |
| 2020 | 4.83M | -20.72M | -428.44% |
| 2021 | 1.52M | -8.11M | -531.72% |
| 2022 | 60K | -10.17M | -16961.67% |
| 2023 | 184K | -5.56M | -3026.63% |
TTNP Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 184K | 60K | 1.52M | 4.83M | 3.61M | 5.91M | 215K | 15.06M | 1.67M | 3.64M |
Cost of revenue | 1.91M | 196K | 199K | 472K | 1.28M | 538K | 9.64M | 6.12M | 4.67M | 4.07M |
Gross profit | -1.72M | -136K | 1.32M | 4.36M | 2.32M | 5.37M | -9.43M | 8.93M | -3.00M | -429K |
Operating exp. | ||||||||||
Research and development | 1.91M | 4.75M | 5.69M | 5.91M | 7.24M | 7.47M | 9.64M | 6.12M | 4.67M | 4.07M |
Selling and marketing | 0 | 0 | 0 | 0 | 6.52M | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 7.46M | 10.29M | 10.68M | 11.71M | 19.16M | 13.63M | 14.71M | 10.72M | 8.43M | 7.12M |
Operating income | -7.27M | -10.23M | -9.35M | -7.35M | -16.84M | -8.26M | -14.50M | 4.34M | -6.75M | -3.47M |
Other income (expenses), net | 1.70M | 29K | 578K | -56K | 386K | 128K | 195K | 755K | -4.52M | 1.07M |
Income before tax | -5.56M | -10.20M | -8.77M | -7.40M | -16.45M | -9.02M | -14.30M | 5.13M | -11.27M | -2.40M |
Income tax expense | 0 | -29K | -662K | 13.32M | -369K | -1.64M | -250K | -792K | 4.52M | -1.07M |
Net income | -5.56M | -10.17M | -8.11M | -20.72M | -16.08M | -9.02M | -14.30M | 5.13M | -11.27M | -2.40M |
Earnings per share | ||||||||||
Basic EPS | -7.41 | -15.15 | -16.68 | -109.88 | -12.60K | -47.59 | -121.48 | 44.71 | -101.24 | -25.36 |
Diluted EPS | -7.41 | -15.15 | -16.68 | -109.88 | -12.60K | -47.59 | -121.34 | 36.01 | -101.24 | -25.35 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |